Skip to content

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

  1. Home/
  2. News/
  3. Innovation/
  4. Health Partner: The digital tool that can help you navigate your knee, hip or weight-loss journey
Runner holding knee

Health Partner: The digital tool that can help you navigate your knee, hip or weight-loss journey

Grappling with joint or weight issues? Enter The Health Partner for Knees, Health Partner for Hips and Health Partner for Weight Loss Surgery suite of websites and apps—unveiled this week at the Consumer Electronics Show.

Joint pain from injuries or medical conditions like arthritis is a daily reality for many Americans: Each year, an estimated 660,000 people undergo knee-replacement surgery, and more than 300,000 have hip-replacement surgery. And Americans with a body mass index of 40 or higher (or 35 or higher if they have a condition like diabetes) who have unsuccessfully tried diet and exercise to keep their weight down have bariatric surgery as a treatment option for achieving sustainable weight loss.

But regardless of the ailment or illness people may face, there is one thing many of us share in common: navigating the healthcare journey can be a challenging, confusing and overwhelming experience.

That’s why Johnson & Johnson has created Health Partner, a new digital solution focused on helping patients through that journey.

It’s made up of three applications— Health Partner for Knees, Health Partner for Hips and Health Partner for Weight Loss Surgery—and it’s debuting this week at the Consumer Electronics Show in Las Vegas.

“Many health issues prevent people from living the life they want,” says Len Greer, President, Johnson & Johnson Health and Wellness Solutions. “Our main goal is to assist people through their healthcare journey—and ultimately get them back to an active life, and back to optimal health.”

Here’s how.

CES Health Partner Infographic-compressed.jpg

More from Johnson & Johnson

Juvenile myasthenia gravis: Inside one adolescent’s journey

The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

Teaming up to support healthcare in the local community and empower residents.